Annual Cash & Cash Equivalents
$69.55 M
+$35.27 M+102.92%
December 31, 2023
Summary
- As of February 8, 2025, VRCA annual cash & cash equivalents is $69.55 million, with the most recent change of +$35.27 million (+102.92%) on December 31, 2023.
- During the last 3 years, VRCA annual cash & cash equivalents has risen by +$58.86 million (+550.82%).
- VRCA annual cash & cash equivalents is now at all-time high.
Performance
VRCA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$22.96 M
-$8.97 M-28.10%
September 30, 2024
Summary
- As of February 8, 2025, VRCA quarterly cash and cash equivalents is $22.96 million, with the most recent change of -$8.97 million (-28.10%) on September 30, 2024.
- Over the past year, VRCA quarterly cash and cash equivalents has dropped by -$61.35 million (-72.77%).
- VRCA quarterly cash and cash equivalents is now -77.74% below its all-time high of $103.15 million, reached on June 30, 2018.
Performance
VRCA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VRCA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +102.9% | -72.8% |
| 3 y3 years | +550.8% | -33.0% |
| 5 y5 years | +577.1% | -33.0% |
VRCA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +341.5% | -72.8% | +322.8% |
| 5 y | 5-year | at high | +652.6% | -72.8% | +322.8% |
| alltime | all time | at high | >+9999.0% | -77.7% | +322.8% |
Verrica Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $22.96 M(-28.1%) |
| Jun 2024 | - | $31.93 M(-34.8%) |
| Mar 2024 | - | $48.94 M(-29.6%) |
| Dec 2023 | $69.55 M(+102.9%) | $69.55 M(-17.5%) |
| Sep 2023 | - | $84.31 M(+52.9%) |
| Jun 2023 | - | $55.14 M(-8.0%) |
| Mar 2023 | - | $59.95 M(+74.9%) |
| Dec 2022 | $34.27 M(+117.6%) | $34.27 M(+5.5%) |
| Sep 2022 | - | $32.47 M(+498.0%) |
| Jun 2022 | - | $5.43 M(-47.8%) |
| Mar 2022 | - | $10.41 M(-33.9%) |
| Dec 2021 | $15.75 M | $15.75 M(-22.9%) |
| Sep 2021 | - | $20.44 M(-17.3%) |
| Jun 2021 | - | $24.71 M(-44.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $44.10 M(+312.7%) |
| Dec 2020 | $10.69 M(+15.6%) | $10.69 M(-37.9%) |
| Sep 2020 | - | $17.20 M(-64.9%) |
| Jun 2020 | - | $48.93 M(-10.2%) |
| Mar 2020 | - | $54.49 M(+489.6%) |
| Dec 2019 | $9.24 M(-10.0%) | $9.24 M(-12.8%) |
| Sep 2019 | - | $10.60 M(-46.6%) |
| Jun 2019 | - | $19.85 M(-18.7%) |
| Mar 2019 | - | $24.43 M(+137.8%) |
| Dec 2018 | $10.27 M(+18.6%) | $10.27 M(-73.2%) |
| Sep 2018 | - | $38.31 M(-62.9%) |
| Jun 2018 | - | $103.15 M(+275.3%) |
| Mar 2018 | - | $27.48 M(+217.3%) |
| Dec 2017 | $8.66 M(+1543.8%) | $8.66 M |
| Dec 2016 | $527.00 K | - |
FAQ
- What is Verrica Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Verrica Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Verrica Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of VRCA is $69.55 M
What is the all time high annual cash & cash equivalents for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high annual cash & cash equivalents is $69.55 M
What is Verrica Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, VRCA annual cash & cash equivalents has changed by +$35.27 M (+102.92%)
What is Verrica Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of VRCA is $22.96 M
What is the all time high quarterly cash and cash equivalents for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high quarterly cash and cash equivalents is $103.15 M
What is Verrica Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, VRCA quarterly cash and cash equivalents has changed by -$61.35 M (-72.77%)